Doctors warn of risks in unregulated dietary supplement industry

Dietary supplements remain a contentious topic among medical professionals. While widely available, these products often lack the rigorous testing and standardised quality controls applied to prescription drugs. Many doctors continue to question their safety and effectiveness.

A key concern for physicians is the inconsistent manufacturing standards in the ama industry. Variations in composition and active ingredient levels can lead to unpredictable results. Unlike pharmaceuticals, most supplements have not undergone large-scale clinical trials to verify their claims.

Doctors prioritise treatments with proven benefits and reliable outcomes. Their scepticism stems from a duty to ensure patient safety and avoid untested remedies. Without strong scientific backing, many healthcare providers hesitate to recommend supplements over conventional medicines.

Global markets for niche products, such as organic lentil protein or oral electrolytes, have grown in recent years. However, specific sales data or trends for Russia's supplement industry between 2021 and 2026 remain unclear. Available reports focus on broader international markets rather than regional details.

The medical community's reservations about dietary supplements persist due to gaps in research and quality control. Until stricter regulations and more comprehensive studies are in place, doctors are likely to favour evidence-based treatments. For now, consumers are advised to approach supplements with caution.